Cheng Hu,James Sutton,Keith B. Pfister,Martin Sendzik,Paul A.Barsanti
申请号：
BR112012004836
公开号：
BR112012004836A2
申请日:
2010.09.02
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor.
